Telix Pharmaceuticals Limited

TLXNASDAQHealthcare● Active

$9.29

$-0.01(-0.11%)

Market Cap$3.1B

P/E Ratio—

52W High$18.49

52W Low$6.28

Avg Volume200K

Open$9.40

Beta0.59

Overview

Telix Pharmaceuticals Limited (TLX) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · TLX · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Telix Pharmaceuticals Limited insiders have shown mixed buying and selling activity over the past 12 Months.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

TLX insider buying and selling by quarter

TLX insider selling · TLX insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

5K3K0

2003 Q3

2004 Q1

2004 Q2

2006 Q1

2007 Q3

2007 Q4

2010 Q4

2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Recent insider transactions

TLX executive sell shares · TLX board member insider trading · TLX insider trading SEC filing

Showing 2 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Sep 11, 2007	BRANDT RICHARD PAUL Director	Option	2,500	$4.03	$10K	5,160	Form 4
Sep 11, 2007	BRANDT RICHARD PAUL Director	Other	1,765	$5.70	$10K	3,395	Form 4

Date

Insider

Type

Value

Filing

Sep 11, 2007

BRANDT RICHARD PAUL

Director

Option

2,500

$10K

Form 4

Sep 11, 2007

BRANDT RICHARD PAUL

Director

Other

1,765

$10K

Form 4

BRANDT RICHARD PAUL

Director

Option

Date

Sep 11

2,500

Price

$4.03

Value

$10K

View Form 4 on SEC.gov

BRANDT RICHARD PAUL

Director

Other

Date

Sep 11

1,765

Price

$5.70

Value

$10K

View Form 4 on SEC.gov

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About TLX insider trading

TLX insider trades

Telix Pharmaceuticals Limited (TLX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including TLX. Over the past 12 months, 0 insiders have filed transactions with the SEC. TLX insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Telix Pharmaceuticals Limited's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

TLX insider trading · 5 questions

The insiders of Telix Pharmaceuticals Limited (TLX) include executives and directors such as TLX, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

TLX board member insider tradingwho are TLX insidersTLX insider rosterTelix Pharmaceuticals Limited executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026